AAAAAA
Results: 1-25/31
Authors:
Frater, JL
McCarron, KF
Hammel, JP
Shapiro, JL
Miller, ML
Tubbs, RR
Pettay, J
Hsi, ED
Citation: Jl. Frater et al., Typical and atypical chronic lymphocytic leukemia differ clinically and immunophenotypically, AM J CLIN P, 116(5), 2001, pp. 655-664
Authors:
Hsi, ED
Citation: Ed. Hsi, The search for meaningful prognostic markers in diffuse large B-cell lymphoma, AM J CLIN P, 115(4), 2001, pp. 481-483
Authors:
Hsi, ED
Yegappan, S
Citation: Ed. Hsi et S. Yegappan, Lymphoma immunophenotyping: A new era in paraffin-section immunohistochemistry, ADV ANAT PA, 8(4), 2001, pp. 218-239
Authors:
Frater, JL
Tsiftsakis, EK
Hsi, ED
Pettay, J
Tubbs, RR
Citation: Jl. Frater et al., Use of novel t(11;14) and t(14;18) dual-fusion fluorescence in situ hybridization probes in the differential diagnosis of lymphomas of small lymphocytes, DIAGN MOL P, 10(4), 2001, pp. 214-222
Authors:
Yegappan, S
Schnitzer, B
Hsi, ED
Citation: S. Yegappan et al., Follicular lymphoma with marginal zone differentiation: Microdissection demonstrates the t(14;18) in both the follicular and marginal zone components, MOD PATHOL, 14(3), 2001, pp. 191-196
Authors:
Yegappan, S
Coupland, R
Arber, DA
Wang, N
Miocinovic, R
Tubbs, RR
Hsi, ED
Citation: S. Yegappan et al., Angiotropic lymphoma: An immunophenotypically and clinically heterogeneouslymphoma, MOD PATHOL, 14(11), 2001, pp. 1147-1156
Authors:
Wrone-Smith, T
Izban, KF
Ergin, M
Cosar, EF
Hsi, ED
Alkan, S
Citation: T. Wrone-smith et al., Transfection of caspase-3 in the caspase-3-deficient Hodgkin's disease cell line, KMH2, results in enhanced sensitivity to CD95-, TRAIL-, and ARA-C-induced apoptosis, EXP HEMATOL, 29(5), 2001, pp. 572-581
Authors:
Ormsby, A
Bergfeld, WF
Tubbs, RR
Hsi, ED
Citation: A. Ormsby et al., Evaluation of a new paraffin-reactive CD7 T-cell deletion marker and a polymerase chain reaction-based T-cell receptor gene rearrangement assay: Implications for diagnosis of mycosis fungoides in community clinical practice, J AM ACAD D, 45(3), 2001, pp. 405-413
Authors:
Yang, B
Tubbs, RR
Hsi, ED
Finn, W
Citation: B. Yang et al., Molecular genetic characterization of primary cutaneous B-cell lymphomas -Authors' reply, AM J SURG P, 25(4), 2001, pp. 538-539
Authors:
Shehab, TM
Hsi, ED
Poterucha, JJ
Gunaratnam, NT
Fontana, RJ
Citation: Tm. Shehab et al., Helicobacter pylori-associated gastric malt lymphoma in liver transplant recipients, TRANSPLANT, 71(8), 2001, pp. 1172-1175
Authors:
Hsi, ED
Citation: Ed. Hsi, Towards a molecular classification of hematolymphoid neoplasms: Where are we now? Where are we going?, J HIST CYTO, 49(10), 2001, pp. 1323-1324
Authors:
Chen, Q
Gong, B
Mahmoud-Ahmed, AS
Zhou, A
Hsi, ED
Hussein, M
Almasan, A
Citation: Q. Chen et al., Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced in multiple myeloma, BLOOD, 98(7), 2001, pp. 2183-2192
Authors:
Hsi, ED
Citation: Ed. Hsi, A practical approach for evaluating new antibodies in the clinical immunohistochemistry laboratory, ARCH PATH L, 125(2), 2001, pp. 289-294
Authors:
Roche, PC
Hsi, ED
Citation: Pc. Roche et Ed. Hsi, Immunohistochemistry: Theory and practice, MORPHOLOGY METHODS, 2001, pp. 229-237
Authors:
Hsi, ED
Citation: Ed. Hsi, Paroxysmal nocturnal hemoglobinuria testing by flow cytometry - Evaluationof the REDQUANT and CELLQUANT kits, AM J CLIN P, 114(5), 2000, pp. 798-806
Authors:
McCarron, KF
Hammel, JP
Hsi, ED
Citation: Kf. Mccarron et al., Usefulness of CD79b expression in the diagnosis of B-cell chronic lymphoproliferative disorders (vol 113, pg 805, 2000), AM J CLIN P, 114(3), 2000, pp. 489-489
Authors:
Hsi, ED
Hoeltge, G
Tubbs, RR
Citation: Ed. Hsi et al., Biclonal chronic lymphocytic leukemia, AM J CLIN P, 113(6), 2000, pp. 798-804
Authors:
McCarron, KF
Hammel, JP
Hsi, ED
Citation: Kf. Mccarron et al., Usefulness of CD79b expression in the diagnosis of B-cell chronic lymphoproliferative disorders, AM J CLIN P, 113(6), 2000, pp. 805-813
Authors:
Sigel, JE
Hsi, ED
Citation: Je. Sigel et Ed. Hsi, Immunohistochemical analysis of CD30-positive lymphoproliferative disorders for expression of CD95 and CD95L, MOD PATHOL, 13(4), 2000, pp. 446-451
Authors:
Skacel, M
Ross, CW
Hsi, ED
Citation: M. Skacel et al., A reassessment of primary thyroid lymphoma: high-grade MALT-type lymphoma as a distinct subtype of diffuse large B-cell lymphoma, HISTOPATHOL, 37(1), 2000, pp. 10-18
Authors:
Schumann, KW
Oriba, HA
Bergfeld, WF
Hsi, ED
Hollandsworth, K
Citation: Kw. Schumann et al., Cutaneous presentation of posttransplant lymphoproliferative disorder, J AM ACAD D, 42(5), 2000, pp. 923-926
Authors:
Yang, B
Tubbs, RR
Finn, W
Carlson, A
Pettay, J
Hsi, ED
Citation: B. Yang et al., Clinicopathologic reassessment of primary cutaneous B-cell lymphomas with immunophenotypic and molecular genetic characterization, AM J SURG P, 24(5), 2000, pp. 694-702
Authors:
Yang, F
Tran, TA
Carlson, JA
Hsi, ED
Ross, CW
Arber, DA
Citation: F. Yang et al., Paraffin section immunophenotype of cutaneous and extracutaneous mast celldisease - Comparison to other hematopoietic neoplasms, AM J SURG P, 24(5), 2000, pp. 703-709
Authors:
Hsi, ED
Singleton, TP
Swinnen, L
Dunphy, CH
Alkan, S
Citation: Ed. Hsi et al., Mucosa-associated lymphoid tissue-type lymphomas occurring in post-transplantation patients, AM J SURG P, 24(1), 2000, pp. 100-106
Authors:
Izban, KF
Alkan, S
Singleton, TP
Hsi, ED
Citation: Kf. Izban et al., Multiparameter immunohistochemical analysis of the cell cycle proteins cyclin D1, Ki-67, p21(WAF1), p27(KIP1), and p53 in mantle cell lymphoma, ARCH PATH L, 124(10), 2000, pp. 1457-1462